Anxiety - Articles - Page 2 | CARLAT PUBLISHING

Screen Shot 2023-11-12 at 1.13.49 PM.png

Ketamine: Six New Findings Part 2

November 13, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

New research brings clarity to the big ketamine questions. How does it compare to ECT and antipsychotics? How much of it is placebo? Which is more effective – ketamine or esketamine? How do you sustain the benefits? Does it work better with psychotherapy?

Screen Shot 2023-11-05 at 6.56.55 PM.png

Ketamine: Six New Findings Part 1

November 6, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

New research brings clarity to the big ketamine questions. How does it compare to ECT and antipsychotics? How much of it is placebo? Which is more effective – ketamine or esketamine? How do you sustain the benefits? Does it work better with psychotherapy?

Expert Q&A

When and How Should We Prescribe Benzos?

October 31, 2023

Tae Woo (Ted) Park, MD

Tae Woo (Ted) Park, MD. Assistant professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Dr. Park has no financial relationships with companies related to this material.

Despite their risks, benzodiazepines remain a widely prescribed class of medication. In the prescriber right hands, benzodiazepines can help many patients cope with a variety of psychiatric issues. Here, Dr. Park reviews how to evaluate patients prior to starting benzodiazepines and reviews strategies to ensure that prescriptions are done safely.

Bipolar Upgrade 6: Dark Therapy

September 11, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on dark therapy for mania from the 2023 International Bipolar Conference.

Throwback Thursday: Neuroticism and SSRIs

September 7, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

"I think that anxiety is the fever of psychiatry, not a disease, it's not a diagnosis, it's not an illness. It's just a symptom, usually of other illnesses or condition." - Nassir Ghaemi

Research Update

Can Abstaining From Social Media Help People Feel Better?

April 14, 2023

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has no financial relationships with companies related to this material.

What happens when 154 volunteers are randomized to stay off the screen for a week?

Research Update

Stimulant Treatment Effect on Anxiety in ADHD

April 1, 2023

Gaurav Mishra, MD

Gaurav Mishra, MD. Dr. Mishra has no financial relationships with companies related to this material.

Are stimulant medication likely to exacerbate anxiety in ADHD kids? It’s reasonable concern, especially since mood symptoms can be worse with withdrawal and heart rate goes up in some kids on stimulants. This study gives nuanced insight into the degree to which stimulants impact anxiety in ADHD kids, for better and worse.

CLINICAL UPDATE

Trichotillomania: Diagnosis and Treatment

October 30, 2022

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has no financial relationships with companies related to this material.

Trichotillomania (TTM) is a disorder that seems to lurk in the shadows. We hear about it but rarely see it.

Interpreting Assessment Discrepancies from Multiple Sources

October 17, 2022

Joshua Feder, MD and Mara Goverman

In this episode, we will discuss why assessment discrepancies arise, how we can manage them, and what these discrepancies tell us about a patient’s symptoms and response to treatment.